Scholarships and Research Support
Glaucoma Australia – Australia & New Zealand Glaucoma Society Scholarship
Glaucoma Australia and The Australian and New Zealand Glaucoma Society (ANZGS) jointly award Scholarships each year to enable trainees in glaucoma to attend the annual ANZGS Scientific Meeting.
Glaucoma Australia is a national not-for-profit association dedicated solely to providing educational services to raise awareness about the serious and common eye disease glaucoma; to support people with glaucoma and to raise funds for glaucoma research.
Supporting Australian glaucoma research is an important component of our work. The William A Quinlivan – Glaucoma Australia Research and Scholarship Fund is concerned exclusively with:
It finances highly qualified clinicians, scientists and researchers to conduct glaucoma research. The Fund has previously supported the Chair of Glaucoma at the University of Melbourne.
Currently Glaucoma Australia is funding the Targeting At Risk Relatives of Glaucoma patients for Early diagnosis and Treatment (TARRGET) study, which is a partnership project between Glaucoma Australia and the Australian and New Zealand Registry of Advanced Glaucoma (based at Flinders University, Adelaide).
TARRGET aims to investigate the feasibility of offering free glaucoma screening to immediate relatives of people who have been diagnosed with advanced glaucoma. We hypothesise that relatives of those people severely affected by glaucoma will have higher rates of glaucoma diagnosis than relatives of less severely affected glaucoma patients. The study has been contacting 100 randomly selected South Australian participants in the Registry of Advanced Glaucoma to complete their family trees of immediate relatives (parents, siblings and children). These participants have been invited to ask their immediate family if they would be willing to have a free, comprehensive glaucoma examination. Our aim is to attain clinical information to confirm glaucoma status for as many first degree relatives as possible.
Early results show that for every 5 immediate relatives screened, a new case is detected that will either need close monitoring for the development of glaucoma or will be diagnosed as definite glaucoma. Data so far indicates family members of people with advanced glaucoma appear to have a 50% chance of showing at least the early signs of glaucoma. As the project unfolds, we will look to advocate for better screening pathways for these individuals. This may involve lobbying for altered Medicare structures for nerve fibre layer testing and ongoing screening of family members.
Glaucoma Australia has previously partnered with The Ophthalmic Research Institute of Australia’s (ORIA); the research arm of the Royal Australian and New Zealand College of Ophthalmologist.
Past Research Award Ceremony
L to R: Prof Ivan Goldberg - Vice President, Glaucoma Australia;
Prof Robert Casson; Prof Jamie Craig; Beverley Lindsell - Past National Executive Officer;
Prof Jonathan Crowston and Michael Braham - Past President, Glaucoma Australia
Past Research Award Ceremony
L to R: Prof Glen Gole; Geoff Pollard, National Executive Officer Glaucoma Australia;
Prof Stuart Graham
Listed below are some Glaucoma Australia / ORIA grant recipients:
Prof Minas T Coroneo, Dr Agar Ashish and Dr Mark Hill - The Effects of Pressure on Retinal Ganglion Cell Survival In-Vitro
Prof Peter McCluskey, Alex Dempster, Prof ACB (Tony) Molteno, Prof Denis Wakefield - The Role of Matrix Metallooproteinases in the Development of Filtration Blebs following Molteno Valve Insertion
Prof David Mackey - The Twin Eye Studies in Tasmania to investigate genetic and environmental contributions to glaucoma and other eye diseases.
Prof Jonathan Crowston and Dr Paul Healey - Regulating wound healing after glaucoma filtration surgery by priming Tenon’s fibroblast for apoptosis.
Dr A. Martins, Prof Stuart Graham and Dr Alexander Klistorner - Spectral (Blue-Yellow) Objective Perimetry in Normal and Diseased States
Dr Colin I Clement - Hyperhomocystinaemia in Glaucoma
Mr Michael Ward, Assoc/Prof Ross McKinnon - Genetic determinants of beta-blocker eye drop efficacy in glaucoma patients
Assoc/Prof Jamie Craig and Dr Nick Voelcker - Miniaturised Implantable Sensors for Eye Pressure Measurement
Assoc/Professor Robert Casson - Bioenergetic-Based Neuroprotection for the Treatment of Retinal and Optic
Dr Kathryn Burdon - Genetic Investigations of Central Corneal Thickness in Relation to Blinding Glaucoma
Dr Glyn Chidlow & Assoc/Prof Robert Casson - The Role of Osteopontin in the Retina
Prof Jonathan Crowston & Dr Ian Trounce - Oxidative Phosphorylation defects and the optic nerve response to acute IOP injury in the xenomitochondrial mouse
Assoc/Prof Jamie Craig & Dr Alex Hewitt - Proteomic and Genomic Strategies to Identify the Molecular Basis of PEX
Dr John Wood & Dr Glyn Chidlow - The Role of Tau in Experimental Glaucoma
Professor Glen Gole, Dr Nigel Barnett & Professor Steven Bottle - Evaluating a novel (two-way i.e. reversible) technique to measure oxidation (or reduction) in retinal cells in an experimental glaucoma model.
Dr Alex Hewitt, Dr Mirella Dottori & Dr Bryony Nayagam - Developing a patient-specific model for glaucoma.
Dr Kathryn Burdon & Ms Emmanuelle Souzeau - Identifying genetic causes of primary congenital glaucoma in Australia
We invite you to be part of this important fund which supports Australian glaucoma research. Contributions to the William A Quinlivan – Glaucoma Australia Research and Scholarship Fund are tax deductible ($2 or over) and would be acknowledged with appreciation.
Please help us to eliminate glaucoma blindness
About William A Quinlivan:
Believing that Research and Scholarship gives hope for more effective treatment and the ultimate cure of glaucoma, this special fund was proposed and initially funded by Marcus Quinlivan OAM, the son of the late William A Quinlivan, in honour of his father.
William Alfred Quinlivan was born on 6th August 1883 at Myrtleford, Victoria. He served in the Australian Army (AIF) in World War 1 as a member of the 22nd Battalion and was involved in battles on the Western Front including major battles at Bullecourt and Villers-Bretonneux, where he was severely gassed and temporarily blinded. Eventually he returned to Australia where he continued to suffer from the effects of gas until his death at an early age in 1936.
William Quinlivan is remembered for his quiet sense of humour, his caring nature, his kindness and the practical help he gave underprivileged people particularly during the depression years of the 1930s. He was not backward in challenging injustice.